• Alvarnas, J.C., Negrin, R.S., Horning, S.J., Hu, W.W., Long, G.D., Schriber, J.R., Stockerl-Goldstein, K., Tierney, K., Wong, R., Blume, K.G. & Chao, N.J. (2000) High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma. Biology of Blood and Marrow Transplantation, 6, 352358.
  • van Besien, K., Przepiorka, D., Mehra, R., Giralt, S., Khouri, I., Gajewski, J., Andersson, B. & Champlin, R. (1996) Impact of preexisting CNS involvement on the outcome of bone marrow transplantation in adult hematologic malignancies. Journal of Clinical Oncology, 14, 30363042.
  • van Besien, K., Ha, C.S., Murphy, S., McLaughlin, P., Rodriguez, A., Amin, K., Forman, A., Romaquera, J., Hagemeister, F., Younes, A., Bachier, C., Sarris, A., Sobocinski, K.S., Cox, J.D. & Cabanillas, F. (1998) Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood, 91, 11781184.
  • Boehme, V., Schmitz, N., Zeynalova, S., Loeffler, M. & Pfreundschuh, M. (2009) CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood, 113, 38963902.
  • Bromberg, J.E., Doorduijn, J.K., Illerhaus, G., Jahnke, K., Korfel, A., Fischer, L., Fritsch, K., Kuittinen, O., Issa, S., van Montfort, C. & van den Bent, M.J. (2013) Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation - an International Primary Central Nervous System Lymphoma Study Group project. Haematologica, 98, 808813.
  • Cote, G.M., Hochberg, E.P., Muzikansky, A., Hochberg, F.H., Drappatz, J., McAfee, S.L., Batchelor, T.T., LaCasce, A.S., Fisher, D.C., Abramson, J.S., Armand, P. & Chen, Y.B. (2012) Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma. Biology of Blood and Marrow Transplantation, 18, 7683.
  • D'Agostino, R.B. Jr (1998) Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statistics in Medicine, 17, 22652281.
  • Deckert, M., Engert, A., Bruck, W., Ferreri, A.J., Finke, J., Illerhaus, G., Klapper, W., Korfel, A., Kuppers, R., Maarouf, M., Montesinos-Rongen, M., Paulus, W., Schlegel, U., Lassmann, H., Wiestler, O.D., Siebert, R. & DeAngelis, L.M. (2011) Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. Leukemia, 25, 17971807.
  • Doolittle, N.D., Abrey, L.E., Shenkier, T.N., Tali, S., Bromberg, J.E., Neuwelt, E.A., Soussain, C., Jahnke, K., Johnston, P., Illerhaus, G., Schiff, D., Batchelor, T., Montoto, S., Kraemer, D.F. & Zucca, E. (2008) Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report. Blood, 111, 10851093.
  • Ferreri, A.J. (2011) How I treat primary CNS lymphoma. Blood, 118, 510522.
  • Horowitz, M. (2008) The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. Bone Marrow Transplantation, 42, S1S2.
  • Jahnke, K., Thiel, E., Martus, P., Schwartz, S. & Korfel, A. (2006) Retrospective study of prognostic factors in non-Hodgkin's lymphoma secondarily involving the central nervous system. Annals of Hematology, 85, 4550.
  • Jaime-Perez, J.C., Rodriguez-Romo, L.N., Gonzalez-Llano, O., Chapa-Rodriguez, A. & Gomez-Almaquer, D. (2009) Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy. British Journal of Haematology, 144, 794795.
  • Kasamon, Y.L., Jones, R.J., Piantadosi, S., Ambinder, R.F., Abrams, R.A., Borowitz, M.J., Morrison, C., Smith, B.D. & Flinn, I.W. (2005) High-dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biology of Blood and Marrow Transplantation, 11, 93100.
  • Korfel, A., Elter, T., Thiel, E., Hänel, M., Möhle, R., Schroers, R., Reiser, M., Dreyling, M., Eucker, J., Scholz, C., Metzner, B., Röth, A., Birkmann, J., Schlegel, U., Martus, P., Illerhaus, G. & Fischer, L. (2013) Phase II study of central nervous system (CNS)-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation for CNS relapse of aggressive lymphomas. Haematologica, 98, 364370.
  • Siegal, T. & Goldschmidt, N. (2012) CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom? Blood Reviews, 26, 97106.
  • Villa, D., Connors, J.M., Shenkier, T.N., Gascoyne, R.D., Sehn, L.H. & Savage, K.J. (2010) Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy. Annals of Oncology, 21, 10461052.
  • Villela, L., Garcia, M., Caballero, R., Borbolla-Escoboza, J.R. & Bolanos-Meade, J. (2008) Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma. Anti-Cancer Drugs, 19, 917920.
  • Williams, C.D., Pearce, R., Taghipour, G., Green, E.S., Philip, T. & Goldstone, A.H. (1994) Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome–a report by the European Bone Marrow Transplant Lymphoma Registry. Journal of Clinical Oncology, 12, 24152422.